Speakers from Touchstone Exploration, Shanta Gold, Savannah Resources and Kavango Resources feature in our Natural Resources webinar on May 25th. Please register here.

Less Ads, More Data, More Tools Register for FREE

Incanthera senior management present at London South East's April Investor Webinar


London South East were delighted to welcome Incanthera to our April Investor Webinar last night (6.04.2021), where Chairman Tim McCarthy and CEO Dr Simon Ward presented and took questions.

Incanthera are an AQSE-listed oncology and dermatology therapy business with close ties to the University of Bradford cancer therapy labs. They develop and licence innovative technologies for the treatment of cancer and skin cancer.

They recently raised 1.14M from an oversubscribed share placing which is intended to see them through lucrative commercial negotiations with two global cosmetic companies as they agree licensing arrangements for their innovative anti-skin cancer cream Sol.

By quickly commercialising Sol, they hope to create a regular revenue stream to develop the business as they work on a significant pipeline of other cancer treatments.

The licensing revenues for Sol may be as much as £10M per annum - for a company which currently has a market capitalisation of around £10M, so this is a significant tipping point in the growth of the business.

Incanthera delighted with skin cancer asset Sol, with clinical results 'beyond expectations'

Related Shares

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.